LONDON, Dec 10 () - Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by ​30% compared with standard endocrine therapy, in what it said marked ‌the first big advance in hormonal treatment for the disease in over 20 years. The Swiss ‌drugmaker said detailed results from the phase III lidERA trial showed at three years, 92.

Forecasters continue to predict an 80% chance of favorable weather on Wednesday for the launch of four astronauts on a flight to the moon.

NASA's Hubble Space Telescope got a rare look at the aftermath of two cosmic collisions — and helped scientists solve a decades-old mystery. Many years ago, scientists saw a dense, bright spot near a young star called Fomalhaut. Scientists had stumbled on the dusty debris from two cosmic crashes.